Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Amylyx Pharmaceuticals, Inc. | StockGist | StockGist

Companies
AMLX
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings AMLXSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Amylyx Pharmaceuticals, Inc.

Filed Jan 21, 2026

Accepted Jan 20, 2026, 7:00 PM ET

CIK 0001658551

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

Amylyx Pharmaceuticals, Inc.

Person Type

HC

CUSIP: 03237H101

Amendment History

4 filings

SCHEDULE 13G
Original
Jan 30, 20260000102909-26-000077
SCHEDULE 13G/A
Amendment 1
Viewing
Jan 21, 20260002012383-26-000638
SCHEDULE 13G/A
Amendment 2
Feb 12, 20260000902664-26-000907
SCHEDULE 13G/A
Amendment 3
Latest
Feb 17, 20260001193125-26-054741

Recent Filings

Amylyx Pharmaceuticals, Inc.1 weeks ago

Amylyx Pharmaceuticals, Inc.1 months ago

Amylyx Pharmaceuticals, Inc.1 months ago

Amylyx Pharmaceuticals, Inc.1 months ago

Amylyx Pharmaceuticals, Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice